300 Preclinical pharmacologic characterization of...

European Journal of Cancer 2014 / 11 Vol. 50

300 Preclinical pharmacologic characterization of GSK2849330, a monoclonal AccretaMab® antibody with optimized ADCC and CDC activity directed against HER3

Clarke, N., Hopson, C., Hahn, A., Sully, K., Germaschewski, F., Yates, J., Akinseye, C., Mangatt, B., Jonak, Z., Matheny, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70426-5
Date:
November, 2014
File:
PDF, 68 KB
english, 2014
Conversion to is in progress
Conversion to is failed